Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension

World Journal of Gastroenterology

Volumn 10, Issue 5, 2004, Pages 689-693

  Wang, Ji Jian ^a   Gao, Gen Wu ^a   Gao, Ren Zhong ^b   Liu, Chang An ^a   Ding, Xiong ^a   Yao, Zhen Xiang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b MAROONDAH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; ENDOTHELIN 1; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CARDIOVASCULAR PARAMETERS; CHRONIC DISEASE; CIRCULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMORAL VEIN; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; ILIAC ARTERY; INJECTION; LIVER CIRRHOSIS; NONHUMAN; PERITONEAL CAVITY; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; STATISTICAL ANALYSIS; SUPERIOR MESENTERIC ARTERY; VEIN LIGATION;

EID: 1542580384     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i5.689     Document Type: Article

References (31)

1. Huang YQ, Xiao SD, Zhang DZ, Mo JZ. Nitric oxide synthase distribution in esophageal mucosa and hemodynamic changes in rats with cirrhosis. World J Gastroenterol 1999; 5: 213-216
2. Trevisani F, Sica G, Mainqua P, Santese G, Notariis SD, Caraceni P, Domenicali M, Zaca F, Grazi GL, Mazziotti A, Cavallari A, Bernardi M. Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites. Hepatology 1999; 30: 1387-1392
3. Zhu JY, Leng XS, Wang D, Du RY. Effects of somatostatin on splanchnic hemodynamics in cirrhotic patients with portal hypertension. World J Gastroenterol 2000; 6: 143-144
4. Lebrec D, Moreau R. Pathogenesis of portal hypertension. Eur J Gastroenterol Hepatol 2001; 13: 309-311
5. Tsugawa K, Hashizume M, Migou S, Kishihara F, Kawnaka H, Tomikawa M, Tanoue K, Sugimachi K. Role of nitric oxide and endothelin-1 in a portal hypertensive rat model. Scand J Gastroenterol 2000; 35: 1097-1105
6. Howe LM, Boothe DM, Slater MR, Boothe HW, Wilkie S. Nitric oxide generation in a rat model of acute portal hypertension. Am J Vet Res 2000; 61: 1173-1177
7. Bi XJ, Chen MH, Wang JH, Chen J. Effect of endotoxin on portal hemodynamic in rats. World J Gastroenterol 2002; 8: 528-530
8. Moller S, Bendtsen F, Henriksen JH. Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis. Can J Gastroenterol 2001; 15: 94-106
9. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor α: A major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995; 108: 761-767
10. Lopez-Talavera JC, Cadelina G, Olchowski J, Merrill W, Groszmann RJ. Thalidomide inhibits tumor necrosis factor α, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology 1996; 23: 1616-1621
11. Liu F, Li JX, Li CM, Leng XS. Plasma endothelin in patients with endotoxemia and dynamic comparison between vasoconstrictor and vasodilator in cirrhotic patients. World J Gastroenterol 2001; 7: 126-127
12. Chan CC, Wang SS, Lee FY, Chang FY, Lin HC, Chu CJ, Chen CT, Huang HC, Lee SD. Endothelin-1 induces vasoconstriction on portal-systemic collaterals of portal hypertensive rats. Hepatology 2001; 33: 816-820
13. Nagasue N, Dhra DK, Yamanoi A, Emi Y, Udagawa J, Yamamoto A, Tachibana M, Kubota H, Kohno H, Harada T. Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis. Hepatology 2000; 31: 1107-1114
14. Gottardi AD, Shaw S, Sagesser H, Reichen J. Type A, but not type B, endothelin receptor antagonists significantly decrease portal pressure in portal hypertensive rats. J Hepatol 2000; 33: 733-737
15. Yokoyama Y, Wawrzyniak A, Baveja R, Sonin N, Clemens MG, Zhang JX. Altered endothelin receptor expression in prehepatic portal hypertension predisposes the liver to microcirculatory dysfunction in rats. J Hepatol 2001; 35: 29-36
16. Colombato LA, Albillos A, Groszmana RJ. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats. Hepatology 1991; 15: 323-328
17. Kaviani A, Ohta M, Itani R, Sander F, Tarnawski AS, Sarfeh IJ. Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa. of the rat. J Gastrointest Surg 1997; 1: 371-376
18. Munoz J, Albillos A, Perez-Paramo M, Rossi I, Alvarez-Mon M. Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats. Am J Physiol 1999; 276(3 Pt 1): G687-693
19. Tabrizchi R. The influence of tumour necrosis factor-alpha on the cardiovascular system of anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 2001; 363: 307-321
20. Zhang GL, Wang YH, Teng HL, Lin ZB. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes. World J Gastroenterol 2001; 7: 331-334
21. Wiest R, Shah V, Sessa WC, Groszmann RJ. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 1999; 276(4 Pt 1): G1043-1051
22. Albornoz L, Bandi JC, de las Heras M, Mastai R. Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats. Medicina 2000; 60: 477-481
23. Chen YM, Qian ZM, Zhang J, Chang YZ, Duan XL. Distribution of constitutive nitric oxide synthase in the jejunum of adult rat. World J Gastroenterol 2002; 8: 537-539
24. Wolfard A, Kaszaki J, Szabo C, Balogh Z, Nagy S. Effects of selective nitric oxide synthase inhibition in hyperdynamic endotoxemia in dogs. Eur Surg Res 1999; 31: 314-323
25. Pateron D, Tazi KA, Sogni P, Heller J, Chagneau C, Poirel O, Philippe M, Moreau R, Lebrec D. Role of aortic nitric oxide synthase 3(eNOS) in the systemic vasodilation of portal hypertension. Gastroenterology 2000; 119: 196-200
26. Villa GL, Barletta G, Pantaleo P, Bene RD, Vizzutti F, Vecchiarino S, Masini E, Perfetto F, Tarquini R, Gentilini P, Laffi G. Hemodynamic, renal,and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis. Hepatology 2001; 34: 19-27
27. Kojima H, Yamao J, Tsujimoto T, Uemura M, Takaya A, Fukui H. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance. J Hepatol 2000; 32: 43-50
28. Kojima H, Sakurai S, Kuriyama S, Yoshiji H, Imazu H, Uemura M, Nakatani Y, Yamao J, Fukui H. Endothelin-1 plays a major role in portal hypertension of biliary cirrhotic rats through endothelin receptor subtype B together with subtype A in vivo. J Hepatol 2001; 34: 805-811
29. Taddei S, Virdis A, Ghiadoni L, Salvetti A. Vascular effects of endothelin-1 in essential hypertension: Relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide. J Cardiovasc Pharmacol 2000; 35(4 Suppl 2): S37-40
30. Poo JL, Jimenez W, Maria Munoz R, Bosch-Marce M, Bordas N, Morales-Ruis M, Perez M, Deulofeu R, Sole M, Arroyo V, Rodes J. Chronic blockade of endothelin receptors in cirrhotic rats: Hepatic and hemodynamic effects. Gastroenterology 1999; 116: 161-167
31. Varagic J, Jerkic M, Jovovic D, Nastic-Miric D, Adanja-Grujic G, Markovic-Lipkovski J, Lackovic V, Radujkovic-Kuburovic G, Kentera D. Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats. Am J Med Sci 2000; 320: 171-176